[29P] Testing, property and stability of medicinal formulation,Novel formulations/Development of novel medicines and formulations/Dispensing, prescription audit and ordering,Drug management,Risk management/Formulation testing・In-house formulation・Management of intravenous and enteral nutrition/Others

8:30 AM - 3:00 PM JST(11:30 PM - 6:00 AM UTC)

[29PA-350] Study of Therapeutic Safety and Health Care Economy Effect of Biosimilar Bevacizumab

○Naohiro Ohara¹, Yohei Ikeue¹, Hiromi Sekimoto^2,3, Yoshihisa Honda^2,4, Toshiaki Fukuda¹ (1. Kyoto Medical Center Pharmacy Department, 2. Kyoto Medical Center Clinical Research Center, 3. Doshisha Women's College of Liberal Arts, Department of Pharmacy, Clinical Pharmacy Education and Research Center, 4. Osaka Ohtani University, School of Pharmacy, Clinical Pharmacy Education Center)

Password required to view

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.